Vice President of the Japan Pharmaceutical Manufacturers Association (JPMA) President and Chief Executive Officer, Shionogi & Co., Ltd.
Dr. Teshirogi has been President and CEO of Shionogi & Co., Ltd. since April 2008, and a member of the Board of Directors since June 2002. He joined the Company in April 1982, after graduating from the University of Tokyo. After serving in U.S. branch offices, he was appointed Executive Corporate Officer and Executive General Manager of the Pharmaceutical R&D Division in 2004.
Dr. Teshirogi has served as Vice President of the JPMA since May 2014, after having served as President of the Association for three years, during which time he launched the Asia-Pacific Pharma Congress (APAC) to support the development of the pharmaceutical industry across Asia, promoting collaboration in drug discovery and harmonization of pharmaceutical regulations. Dr. Teshirogi has also shown his commitment to the goal of eliminating infectious diseases, including neglected tropical diseases which can develop into global threats, through his support of the establishment of the Global Health Innovative Technology (GHIT) Fund as a charter member, in partnership with the Bill and Melinda Gates Foundation. He has been Vice President of International Federation of Pharmaceuticals & Associations (IFPMA) since June 2016.
Dr. Teshirogi holds a Ph.D. in Pharmacology from the University of Tokyo.